Joetippensfounded theprotocol(1) after he was told a story about a scientist at merck animal health that had been performingcancerresearch on mice. Remarkably, his joetippensprotocol proved successful, and he remainscancer-free. experience with and perceptions of non-prescription anthelminticsforcancertreatments amongcancerpatients in south korea: Joetippensdeveloped thisprotocolafter learning about a remarkable story involving a scientist at merck animal health who was conductingcancerresearch on mice. As of 2026,joetippensremains alive and reports beingcancer-free for over 8 years, continuing a maintenance version of theprotocol.

General Overview

Joetippensturbocancerprotocolis a high dosage short termprotocolforpeople who have been told there is no other hope with any conventional oncology option and they have days or weeks. Us businessmanjoetippenswas diagnosed with terminal lungcancerin 2016. canceractive proposes a variation on thejoetippensprotocol. Additionally, our previously published article on Feminization Ao3 has gained significant attention for its in-depth coverage of this subject matter. Joetippensacancerpatient who was given three months to live, took a combination of nutrients including fenbendazole, while deciding not to change his diet & it worked. Joetippenspopularized this approach after claiming it contributed to his remission from metastatic small-cell lungcancerin 2017.

Key Points

Readers interested in this topic may also find value in our analysis of Joplin Globe Death Notices which further elaborates on the core themes addressed in this section.